Accelerating high value medical solutions

Convergent technologies for faster, more efficient patient care

Technologies to deliver cost and time savings in the NHS

Strong international connections with healthcare organisations

Deep industry expertise to foster technologies with global potential

People

Our group combines deep, unmatched industry expertise and connections to capital, customers and potential acquirers. These resources will ensure your company gains an ‘unfair’ advantage towards a clear route to market and accelerated sales, exit and value.

Grandees+-

Industry leaders with connections in healthcare and the NHS, capital and links to customers and potential acquirers, bring experience and credibility that appeals to investors.

Taghreed Al-Shunnar

Click for more...

Taghreed Al-Shunnar

Taghreed Al-Shunnar was until March 2011, the Executive Vice President for Strategic Business Development at Hikma Pharmaceuticals, a leading multinational pharmaceutical company with operations in the US, Europe and Middle East and N. Africa (MENA) wherein it has a superior rank and market share.

Taghreed joined Hikma Pharmaceuticals in 1988 after graduating from the University of Jordan with a degree in pharmacy. During the more than 22 years at Hikma, Taghreed took on various roles and responsibilities including sales and marketing, business development and managerial and operational skills, which gave her a great understanding of the health care industry in MENA and connections to health care providers.

Taghreed completed an executive MBA from INSEAD, France in 2007 and is currently pursuing a second masters degree in Consulting and Coaching for Change at INSEAD (CCC) and is expected to graduate in 2011.

Toby Wilson Waterworth

Click for more...

Toby Wilson Waterworth

Toby Wilson Waterworth has extensive experience in the start-up, development and funding of healthcare and technology based businesses, having held senior financial positions in both quoted and unquoted companies.

In 1994 he joined Chiroscience Group plc when it floated on the London Stock Exchange and was involved in raising £44 million prior to its sale to Celltech plc. He joined biopharmaceutical company Alizyme plc when it floated on AiM and was part of a small team involved in raising £35 million over a five year period, building the company to a value of over £200 million and overseeing its admission to the Official List on the London Stock Exchange.

He has founded, turned around and prepared a number of companies for successful IPOs, a number of which are profitable companies. For the last 5 years Toby has been an advisor to the British Government in global healthcare and is CEO of Atlantic Healthcare Ltd.

Toby is a Chartered Accountant and has a BSc in Business Economics.

Paul White

Click for more...

Paul White

Paul White provides top level advisory and consulting support based on over 30 years of highly successful Public and Private sector leadership in Healthcare delivery. Some 18 years of this were as CEO, including over 5 years as CEO of Barts and the London Hospitals Group, one of the UK’s leading Academic Health Science Centres. During this time the organization became the country’s top performing major Health Trust.

Paul was Director, Health Business, BT Global Services, 2008–2009 and CEO of BT Health, London, 2007-2008. His principal focus is at Board and Director level through coaching and helping develop Strategy, Market Positioning, Major Change Management, Performance Improvement and Whole Health Systems.
 Support is provided with deep understanding and management expertise of the environment and challenges facing senior executives and non-executives in Healthcare and organisations supplying goods and services to the Healthcare sector.


Areas covered:

MedTech / Pharma / Software
Angel Investment / Venture Capital / Private Equity
Healthcare / NHS Hospitals



Mentors+-

Successful tech entrepreneurs in pharma, medtech, IT, telecom, media and software, with multiple exits to their name, provide hands-on guidance and support.

David Hampton

Click for more...

David Hampton

David R. Hampton, PhD is an experienced global leader in medical device innovation and new business development, creating profitable new products for diagnostic and informatics markets. Dr. Hampton developed EEG analysis systems for neurology and psychiatry, and later led European and US teams developing interpretive ECG systems and defibrillation technologies to optimize the treatment of cardiac arrest. As an expatriate in the Netherlands, he led Medtronic’s development of subcutaneous monitors for event alerting and was a Fellow at the Bakken Research Center.

Dave is founder and CEO of ‘CamStent Ltd’ (biofilm-resistant medical coatings) and founder and Principal of ‘Stone Bridge Biomedical BV’ (remote patient monitoring systems). He is a senior associate at Cambridge University, UK lecturing in Medical Diagnostics and Devices and was previously Research Director (1999-2003) and Emerging Programs Director (2006-2008) at Medtronic Inc.

Mark Leaning

Click for more...

Mark Leaning

Mark is a successful serial entrepreneur having developed several health technology companies from the initial idea through to successful market growth. This has spanned Australia, the US and the UK. He is the founder of Applied Physiology, a critical care clinical decision support business, and was its first CEO from 2002 to 2009. He was a senior executive and on the Board of HCN (Health Communication Network), Australia’s leading GP software company, responsible for mergers & acquisitions, and technology strategy. Previously he was Chief Operating Officer of Preferred Health Systems (Bethesda, MD, USA) a medical software company he co-founded that was acquired by Magellan Health Services.

An electrical engineer, Mark holds a Master of Science in systems engineering and a PhD in biomedical engineering on the subject of mathematical and computer modeling of physiological systems. He has a wide range of publications in the areas of biomedical engineering, mathematical modeling, artificial intelligence and medical informatics. He is a Visiting Professor at University College London.

Charlotte Mason

Click for more...

Charlotte Mason

Charlotte advises high growth businesses and has a range of experience from Director of an angel investment network – to a mentor of the Astia Entrepreneur Programme, Rockstar Mentoring Group and Cherie Blair Foundation.

Charlotte has lectured Entrepreneurship “pitching for investment” at Cambridge University, is a mentor to the LBS Entrepreneurship Summer School, and a judge at the INSEAD Business Venture Competition.

Charlotte has organised events for UKTI – connecting start-ups to the investment community – is a successful business turnaround expert, a member of NXD Services, an INSEAD MBA, holds a Masters in Manufacturing Engineering and has spent 12-yrs within global IT consulting roles.

Charlotte led a turnaround for a failing £46m turnover company employing 450 people in 6 offices. Under Charlotte’s leadership the company moved EBITDA from 0.7% to 10% EBITDA within 18-months. Charlotte is Co-Chair of the INSEAD UK Alumni Entrepreneur Group, matches talented MBAs from elite business schools to high growth companies and runs Trade Missions to the Isle of Man.


Areas covered:

Pharma / MedTech / Diagnostics
IT / Software / Telecom / Media & Communications
Finance / Exits



Corporate partners+-

Affiliated investment firms invest directly and provide introductions to UK and international equity investors, from seed funding syndicates to series A & B funders.

Hand-picked partners who undertake due diligence of and provide support services for Accelerator companies in accountancy, law, IP, corporate finance and strategic PR/marketing.

Stuart Ager

Click for more...

Stuart Ager

Stuart leads the Finance East Loan Management team after a successful career with NatWest / Royal Bank of Scotland Group and UK Trade and Investment.

He joined NatWest (now part of The Royal Bank of Scotland Group) in 1981. His career with the Bank was concentrated in the SME lending sector. He then joined the Technology Sector Group (TSG) in 1996, moving to the role of Head of TSG in 2000.

Stuart was seconded to the UK Trade & Investment Global Entrepreneur Programme for a period of 2 years from July 2006 and moved from the Bank to lead this Programme in 2008. The GEP focused on assisting the management teams of high growth technology businesses move from overseas to the UK to establish their global HQs here. Stuart was responsible for sourcing key funding lines, introducing professional service providers and assisting with market entry.

He has extensive networks across a range of funders – Grant providers, Business Angels, VCs and Banks – and amongst key professional service providers – Accountants, Lawyers, Executive Recruitment agencies and Intellectual Property specialists.

Marcie Bell

Click for more...

Marcie Bell

Marcie has over 20 years experience in PR and marketing. She now works mostly within the business/investment eco-system but her experience in planning and directing integrated marketing communications projects is broad. She began her career in financial PR in London and, after a move to Scotland, spent 7 years working on consumer and B2B PR campaigns for brands/companies such as Highland Spring, Famous Grouse, Bank of Scotland, British Midland (now BMI) and Scottish Enterprise.

Since re-locating to Cambridge, Marcie has planned and delivered a wide range of high profile projects including Running the Gauntlet, the East of England Development Agency’s investment competition and education programme which attracted approximately 400 applications each year for 3 years and won a Gold in the B2B category of the CIPR awards in two consecutive years. As a result of this and other similar projects, Marcie is experienced in planning and managing pitching events and their associated communications requirements which range from outbound PR/marketing to co-ordinating investor panels managing stakeholder relationships.

Marcie runs The Foundry House. She is a member of the Chartered Institute of Public Relations and a former board member of the MIT Enterprise Forum UK.

Richard Brooks

Click for more...

Richard Brooks

Richard is a chartered accountant with over 25 years experience of working with start ups and SME’s. Richard lives in Cambridge, UK. He is a co-founder of FD Solutions, a company based in London but with clients internationally. FD Solutions provides finance director services on a contract basis to companies. The company has been trading for 20 years and currently employs 27 full time experienced accountants who act as finance directors ( Client Finance Directors) at over 100 businesses including many SME’s, 8 AIM listed businesses. All employees have been finance directors and in some cases managing directors. The team brings a wealth of experience that would not be accessible from employing one full time FD.

Richard is Chief Executive of FD Solutions and in addition to managing the team holds a number of finance director positions. His specialist sectors include technology, manufacturing, and food. His particular skill set includes management information systems design and implementation for growing businesses. Richard is on the Finance Committee of the BioIndustry Association and represents FD Solutions as part of the Business Support Network at the London BioScience Innovation Centre. (LBIC). LBIC established the BSN to provide support and guidance to entrepreneurial start-ups and overseas companies establishing a base at LBIC.

Simon Crossley

Click for more...

Simon Crossley

Simon is a partner in the technology practice of Eversheds, with over ten years’ experience of advising technology companies and institutions investing in or collaborating with technology companies. Based in the Cambridge office, he specialises in transactions that involve the generation and exploitation of new technology and intellectual property rights including license agreements, R&D collaborations, joint ventures, co-promotions and other commercial arrangements.

Simon has particular expertise in and experience of the following industry sectors: pharmaceuticals and biotechnology (including regulatory); IT (including licensing, distribution, system procurement and integration, outsourcing, e-commerce and data protection); semiconductors and mobile/wireless. He also has extensive expertise of academic/commercial technology transfer arrangements, having acted for numerous startup companies spinning out of UK universities such as Cambridge, Imperial, Nottingham and others.

Simon has worked in-house with technology companies as well as in private practice, most recently as EU counsel to a NASDAQ listed US software house. He played an instrumental role in the establishment of ERBI, the leading Cambridge biotechnology networking organization, acting as secretary for a number of years and is asked regularly by Cambridge University to mentor pre-start up technology entrepreneurs.

Gary Hanson

Click for more...

Gary Hanson

Gary leads the BDO office in Cambridge and visits the US several times a year in his role as Country Coordinating Partner, presenting at seminars to transatlantic businesses and their advisors. Gary is a specialist in business advisory services, bringing 32 years of experience to his work. One of his principal skills is UK/US and international operations. He has particular knowledge of US GAAP and its implications – and works closely with the BDO member firm and Alliance network in the USA, as well as being responsible for the relationship and work flow between the UK and US member firms of BDO International. He is also responsible for inward referrals in the East of England region from the International network as a result of which he is currently working with BDO member firms in Australia, France, Germany, Israel, Spain, Holland, Denmark, Sweden and Belgium.

During four years in Cambridge, he has developed an extensive network of contacts across the technology sectors with a particular interest in healthcare and related products and services and advises companies varying in size and structure from early stage to fully listed businesses.

Philip Martin

Click for more...

Philip Martin

Philip heads the Patents Electronics Practice in Cambridge. He specialises in matters relating to patents in the medical devices, electronics, software and telecoms fields, including drafting, filing, prosecution and infringement clearance searching. Philip also has experience of contentious matters including UK and international litigation and has significant drafting experience in the fields of analogue and digital rf circuits and systems, power supply circuits and power semiconductor devices, analogue IC design including A/Ds and amplifier circuits, display driver circuits, and organic semiconductor fabrication. He is a committee member of the Chartered Institute of Patent Attorneys.

Philip graduated from Oxford University with a degree in Physics. After teaching for a year at Charterhouse he went to Cranfield, where he received the top PhD. During his time at Cranfield, Philip was short-listed as the UK’s first astronaut. He then worked for five years as an analogue and digital rf design engineer and latterly as a projects manager, prior to entering private practice, initially focussing on European prosecution work for advanced microprocessors and semiconductor fabrication processes.

Gareth Williams

Click for more...

Gareth Williams

Gareth specialises in biotechnology-related patent work, with particular expertise in genomics and peptides. For his doctorate he conducted research into human molecular biology and genetics, which was funded as part of the Human Genome project. His patent practice includes inventions relating to therapeutic antibodies and proteins, stem cells, pharmaceutical formulations, genetically modified organisms, diagnostic and screening methods, and research tools.

As well as filing and prosecution of patent applications worldwide, Gareth has extensive experience of attending hearings at the European Patent Office. His practice also involves advising on patent term extension, infringement matters and general intellectual property strategy.

He provides freedom to operate and other due diligence reports on complex IP portfolios for clients considering investing in or acquiring IP assets.


Areas covered:

Investment / Law / IP Protection / Accounting
Corporate Advisory / Strategic PR & Marketing



Panel of Experts+-

A panel of healthcare experts offer advice to the med-tech companies pitching to the Accelerator and validate their technologies via their extensive networks.

Penny Dash

Click for more...

Penny Dash

Dr. Penny Dash is a Partner with McKinsey & Co where she leads their work in health systems strategy across EMEA focusing on the redesign of services to improve health, quality and efficiency.

Penny is vice-Chairman of The King’s Fund and co-Founder of the Cambridge Health Network. Previously she was non-executive Director of Monitor and Head of Strategy for the NHS.

Penny started her career as a Doctor, training in Cambridge and London, holds a MSc in Public Health Medicine and is a Member of the Royal College of Physicians of London. She went on to obtain a MBA from Stanford University where she was a Fulbright scholar.

Paul McGhee

Click for more...

Paul McGhee

Paul McGhee is currently Project Manager at Cambridge University Health Partners, the Academic Health Science Centre for the East of England, where he splits his time between promoting the Cambridge Biomedical Campus, and facilitating innovation into health and care services for people with long term health conditions through the Cambridgeshire Health Education and Innovation Cluster. He recently set up a similar cluster in Norwich for The University of East Anglia and its local health partners.

Paul had an international career in communication networks and has been instrumental in the creation of nine start-up organisations, two of which became internationally quoted public companies (BSkyB plc and New Skies Satellites NV) and has helped to launch and market two internet services and three television stations, including NBC and CNBC Europe.

Simon Shohet

Click for more...

Simon Shohet

Simon Shohet has over 15 years management and technology consulting experience, advising board-level executives in pharmaceutical, biotech and medical device companies in both the US and Europe. On the investment side, he has led numerous commercial and technical due diligence assignments, as well as expert reports for venture capital, private equity and corporate finance clients.

Currently he is Practice Director at PopeWoodhead and Associates Ltd based outside Cambridge UK – a consultancy that develops and implements strategies in clinical development, market access and organizational effectiveness for pharmaceutical and medtech clients. Previously he led the UK pharma strategy consulting practice at IMS Health, and has held senior roles in world-leading healthcare product and technology development organizations based in Cambridge. Before entering consulting, Simon was a government affairs adviser at the Confederation of British Industry and a Postdoctoral Fellow at London Business School. He has published several papers and articles in the management and scientific literature and is an editorial board member of the Journal of Commercial Biotechnology. He holds a PhD in microbial biochemistry from UCL.


Areas covered:

Pharma / Biotech / MedTech
IT / Media & Communications
NHS / Healthcare Partnerships
Consulting / Academic Research



T +44 (0) 1223 420 252     E info@atlantic-accelerator.co.uk